This is ACZID-250, an injectable antibiotic containing Ceftazidime (250 mg). It belongs to the third-generation cephalosporin class and is used to treat a variety of serious bacterial infections.

Since this is a prescription-only (Rx) medication for IM/IV use, it should only be administered by a healthcare professional.

Key Details & Usage

• Active Ingredient: Ceftazidime (250 mg).

• Common Uses: It is primarily used to treat severe infections such as:

  • Lower respiratory tract infections (e.g., pneumonia).

  • Urinary tract infections (UTIs).

  • Skin and soft tissue infections.

  • Bacterial meningitis.

  • Sepsis (bloodstream infections).

• Administration: The package includes a vial of powder and an ampoule of sterile water for injection (diluent). Once reconstituted, it is administered via Intramuscular (IM) or Intravenous (IV) injection.

Important Safety Information

Warning: Do not use this medication if the patient has a known allergy to Ceftazidime or other cephalosporins (like Ceftriaxone or Cefixime). Use with caution if there is a history of penicillin allergy, as cross-reactivity can occur.

• Side Effects: Common side effects may include pain or swelling at the injection site, diarrhea, or nausea. Seek immediate medical help if signs of a severe allergic reaction (hives, difficulty breathing, swelling of the face) appear.

• Dosage: The dosage depends strictly on the severity of the infection, the patient’s age, and kidney function.